Primary results of a randomized two‐by‐two factorial phase II trial comparing neoadjuvant chemotherapy with two and four courses of cisplatin/S‐1 and docetaxel/cisplatin/S‐1 as neoadjuvant chemotherapy for advanced gastric cancer

Primary results of a randomized two‐by‐two factorial phase II trial comparing neoadjuvant chemotherapy with two and four courses of cisplatin/S‐1 and docetaxel/cisplatin/S‐1 as neoadjuvant chemotherapy for advanced gastric cancer

Abstract Aim Neoadjuvant chemotherapy (NAC) is promising to improve the survival of resectable gastric cancer. However, suitable regimen and treatment duration for NAC have not yet been established. Methods We conducted a randomized phase II trial to compare two and four courses of neoadjuvant S‐1/c...

Full description

Bibliographic Details
Main Authors: Tsutomu Hayashi, Takaki Yoshikawa, Kentaro Sakamaki, Kazuhiro Nishikawa, Kazumasa Fujitani, Kazuaki Tanabe, Kazunari Misawa, Takanori Matsui, Akira Miki, Hiroshi Nemoto, Tetsu Fukunaga, Yutaka Kimura, Jun Hihara
Format: Article
Language:English
Published: Wiley 2020-09-01
Series:Annals of Gastroenterological Surgery
Subjects:
cisplatin/S‐1
docetaxel/cisplatin/S‐1
gastric cancer
neoadjuvant therapy
Online Access:https://doi.org/10.1002/ags3.12352

Internet

https://doi.org/10.1002/ags3.12352

Similar Items